[Maintaining a remission]

MeSH terms

• Administration, Oral
• Adult
• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / therapeutic use
• Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use
• Azathioprine / administration & dosage
• Azathioprine / therapeutic use
• Budesonide / administration & dosage
• Budesonide / therapeutic use
• Child
• Crohn Disease / diagnosis
• Crohn Disease / drug therapy*
• Crohn Disease / surgery
• Enzyme Inhibitors / administration & dosage
• Enzyme Inhibitors / therapeutic use
• Female
• Folic Acid Antagonists / administration & dosage
• Folic Acid Antagonists / therapeutic use
• Gastrointestinal Agents / administration & dosage
• Gastrointestinal Agents / therapeutic use
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / therapeutic use
• Infliximab
• Male
• Mercaptopurine / administration & dosage
• Mercaptopurine / therapeutic use
• Mesalamine / administration & dosage
• Mesalamine / therapeutic use
• Meta-Analysis as Topic
• Methotrexate / administration & dosage
• Methotrexate / therapeutic use
• Placebos
• Postoperative Care
• Prednisolone / administration & dosage
• Prednisolone / therapeutic use
• Pregnancy
• Prognosis
• Prospective Studies
• Randomized Controlled Trials as Topic
• Recurrence
• Remission Induction
• Risk Factors
• Time Factors